Fernández-Sáez, E. (. M., Losarcos, M. (., Becerril-Mañas, S. (., Valenti-Azcarate, V. (., Moncada, R. (., Martín-Rodríguez, M. (., . . . Rodriguez, A. (. (2023). Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
Citación estilo ChicagoFernández-Sáez, E.M. (Eva M.)|||/items/76f47cdc-eca7-44ab-a9ec-2ce85565da83, et al. Uroguanylin Prevents Hepatic Steatosis, Mitochondrial Dysfunction and Fibrosis in Obesity-associated NAFLD. 2023.
Cita MLAFernández-Sáez, E.M. (Eva M.)|||/items/76f47cdc-eca7-44ab-a9ec-2ce85565da83, et al. Uroguanylin Prevents Hepatic Steatosis, Mitochondrial Dysfunction and Fibrosis in Obesity-associated NAFLD. 2023.
Precaución: Estas citas no son 100% exactas.